Results 161 to 170 of about 39,119 (216)
Some of the next articles are maybe not open access.
Biophysical Chemistry, 2023
Lysozyme amyloidosis is a systemic non-neuropathic disease caused by the accumulation of amyloids of mutant lysozyme. Presently, therapeutic interventions targeting lysozyme amyloidosis, remain elusive with only therapy available for lysozyme amyloidosis
Asra Nasir Khan, Faisal Nabi, R. Khan
semanticscholar +1 more source
Lysozyme amyloidosis is a systemic non-neuropathic disease caused by the accumulation of amyloids of mutant lysozyme. Presently, therapeutic interventions targeting lysozyme amyloidosis, remain elusive with only therapy available for lysozyme amyloidosis
Asra Nasir Khan, Faisal Nabi, R. Khan
semanticscholar +1 more source
Drugs, 1999
Moxilloxacin is a new fluoroquinolone antibacterial agent with a broad spectrum of activity, encompassing gram-negative and gram-positive bacteria. It has improved activity against gram-positive species (including staphylococci, streptococci, enterococci) and anaerobes compared with ciprofloxacin.
J A, Balfour, L R, Wiseman
openaire +2 more sources
Moxilloxacin is a new fluoroquinolone antibacterial agent with a broad spectrum of activity, encompassing gram-negative and gram-positive bacteria. It has improved activity against gram-positive species (including staphylococci, streptococci, enterococci) and anaerobes compared with ciprofloxacin.
J A, Balfour, L R, Wiseman
openaire +2 more sources
2014
A comprehensive profile of moxifloxacin HCl with 198 references is reported. A full description including nomenclature, formulae, elemental analysis, and appearance is included. Methods of preparation for moxifloxacin HCl, its intermediates, and derivatives are fully described.
Mahmoud M H, Al Omari +3 more
openaire +2 more sources
A comprehensive profile of moxifloxacin HCl with 198 references is reported. A full description including nomenclature, formulae, elemental analysis, and appearance is included. Methods of preparation for moxifloxacin HCl, its intermediates, and derivatives are fully described.
Mahmoud M H, Al Omari +3 more
openaire +2 more sources
Clinical pharmacology and therapy, 2020
To prevent antibiotic‐induced perturbations on gut microbiota, DAV132, a novel colon‐targeted adsorbent, which sequesters antibiotic residues in the lower gastrointestinal tract, was developed.
Jinju Guk +6 more
semanticscholar +1 more source
To prevent antibiotic‐induced perturbations on gut microbiota, DAV132, a novel colon‐targeted adsorbent, which sequesters antibiotic residues in the lower gastrointestinal tract, was developed.
Jinju Guk +6 more
semanticscholar +1 more source
Unilateral acute iris transillumination like syndrome following intracameral moxifloxacin injection
Ocular immunology and inflammation, 2020Purpose To describe a case of bilateral acute iris transillumination (BAIT)-like syndrome following intracameral moxifloxacin injection after cataract surgery. Methods A case report. Results We report a case of unilateral acute iris transillumination and
A. Zubicoa +3 more
semanticscholar +1 more source